Evidence map›Paper›PMID 26421484›Full record

ArticleBiomaterials2015

Controlled release of cytokines using silk-biomaterials for macrophage polarization.

Andrew R D Reeves, Kara L Spiller, Donald O Freytes, Gordana Vunjak-Novakovic, David L Kaplan

Abstract read
In one paragraph

Article in Biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 127 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Silk Fibroin Particle-Laden Sponges as a Multiphase Controlled Release Platform.Regenerative engineering and translational medicine · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Nanocomposite Hydrogel for Real-Time Wound Status Monitoring and Comprehensive Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Silk Bioconjugates: From Chemistry and Concept to Application.ACS biomaterials science & engineering · 2024
    Review
  14. Article
  15. Article
  16. Silk chemistry and biomedical material designs.Nature reviews. Chemistry · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Andrew R D ReevesDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA. Electronic address: andrew.reeves@tufts.edu.
Kara L SpillerSchool of Biomedical Engineering, Drexel University, Philadelphia, PA, USA. Electronic address: kls35@drexel.edu.
Donald O FreytesNew York Stem Cell Foundation Research Institute, New York, NY, USA. Electronic address: dfreytes@nyscf.org.
Gordana Vunjak-NovakovicDepartment of Biomedical Engineering, Columbia University, New York, NY, USA. Electronic address: gv2131@columbia.edu.
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA. Electronic address: david.kaplan@tufts.edu.
Tufts University · USColumbia University · USDrexel University · USNew York Stem Cell Foundation · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Tissue Engineering Cornea ReplacementsR01EY020856 · NEI · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2010 to 2016
$2.7M
Degradable orthopedic hardwareR01AR068048 · NIAMS · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L., LIN, SAMUEL J · 2015 to 2020
$2.0M
NEI NIH HHS R01 EY020856NIAMS NIH HHS R01 AR068048NIBIB NIH HHS P41 EB002520
6 · The paper itself

Abstract

Polarization of macrophages into an inflammatory (M1) or anti-inflammatory (M2) phenotype is important for clearing pathogens and wound repair, however chronic activation of either type of macrophage has been implicated in several diseases. Methods to locally control the polarization of macrophages is of great interest for biomedical implants and tissue engineering. To that end, silk protein was used to form biopolymer films that release either IFN-γ or IL-4 to control the polarization of macrophages. Modulation of the solubility of the silk films through regulation of β-sheet (crystalline) content enabled a short-term release (4-8 h) of either cytokine, with smaller amounts released out to 24 h. Altering the solubility of the films was accomplished by varying the time that the films were exposed to water vapor. The released IFN-γ or IL-4 induced polarization of THP-1 derived macrophages into the M1 or M2 phenotypes, respectively. The silk biomaterials were able to release enough IFN-γ or IL-4 to repolarize the macrophage from M1 to M2 and vice versa, demonstrating the well-established plasticity of macrophages. High β-sheet content films that are not soluble and do not release the trapped cytokines were also able to polarize macrophages that adhered to the surface through degradation of the silk protein. Chemically conjugating IFN-γ to silk films through disulfide bonds allowed for longer-term release to 10 days. The release of covalently attached IFN-γ from the films was also able to polarize M1 macrophages in vitro. Thus, the strategy described here offers new approaches to utilizing biomaterials for directing the polarization of macrophages.

Indexed as

Aniline CompoundsAnimalsBiocompatible MaterialsCytokinesDelayed-Action PreparationsHumansInterferon-gammaInterleukin-4MacrophagesMiceMicroscopy, Electron, ScanningPhenotypeProtein Structure, SecondaryReal-Time Polymerase Chain ReactionSilkSolubilityanilineAniline CompoundsBiocompatible MaterialsCytokinesDelayed-Action PreparationsInterferon-gammaInterleukin-4SilkWaterCytokineMacrophagePolarizationSilk

Identifiers

PMID26421484
PMCPMC4605898
OpenAlexW1859923649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.